Journal of Yeungnam Medical Science, published by Yeungnam University College of Medicine and the Yeungnam University Institute of Medical Science, is an innovative open-access journal dedicated to advancing knowledge in the medical sciences. Launched in 2018, this journal encourages the dissemination of high-quality research across a broad range of medical disciplines, reinforcing its commitment to enhancing the global health community. With an E-ISSN of 2799-8010, the journal is centrally located in Daegu, South Korea, and aims to bridge the gap between research and practical application, offering a platform for researchers, professionals, and students. Although the journal is still garnering recognition, as reflected in its overall ranking within the Scopus Multidisciplinary category, it promises to play a vital role in fostering scientific exchange and collaboration. The focus on open access further ensures that groundbreaking research is readily available to a wider audience, aligning with contemporary scholarly communication trends.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.

Advances in Medical Sciences is a peer-reviewed journal published by Elsevier Urban & Partner Sp. z o.o., dedicated to fostering advancements in the field of medicine and healthcare. Established in 2006, this esteemed journal has become a vital resource for researchers, professionals, and students alike, ranking in the Q2 category for Medicine (Miscellaneous) in 2023 and achieving an impressive 84th percentile in the Scopus rankings for General Medicine, placing it at 99 out of 636 journals. With a focus on publishing high-quality research and comprehensive reviews, this journal serves as a platform for disseminating innovative findings that push the boundaries of medical science. Although open access options are not currently available, the journal's rigorous standards ensure that every published article contributes significantly to the global medical community and promotes the understanding of contemporary medical challenges. Located in Wroclaw, Poland, the journal continues to engage a wide readership, driving forward the dialogue in various facets of medical research.

Iatreia is an esteemed academic journal published by the Universidad de Antioquia, Facultad de Medicina, based in Colombia. Since its founding in 1988, the journal has dedicated itself to disseminating valuable research in the field of medicine, focusing on various aspects of general medicine and its interdisciplinary approaches. With an Open Access model that has been in place for over three decades, Iatreia ensures that high-quality medical research is freely accessible to a global audience, promoting knowledge sharing and innovation. Currently categorized in the Q4 quartile for Medicine (Miscellaneous) for 2023, the journal maintains an important position within the medical community, evidenced by its ranking in the 18th percentile on Scopus. As Iatreia advances through its convergence years from 1988 to 2024, it continues to uphold its mission of fostering scholarly dialogue and enhancing the understanding of critical medical issues. Researchers, professionals, and students alike will find Iatreia to be an essential platform for staying abreast of the latest developments and insights in the ever-evolving world of medicine.

REVISTA MEDICA DE CHILE is a distinguished medical journal published by the SOCIEDAD MEDICA SANTIAGO, dedicated to advancing the field of medicine in Chile and beyond. Since its inception in 1945, this journal has served as a vital platform for the dissemination of high-quality research and clinical studies, addressing a wide spectrum of topics within the field of medicine. Currently indexed in Scopus with a rank of 314 out of 636 in the General Medicine category, the journal holds a Q4 categorization and represents the median percentile range, indicating its emerging influence within the scholarly community. Although REVISTA MEDICA DE CHILE does not offer Open Access, it remains accessible to a broad readership keen on exploring recent findings and advancements. Scholars, practitioners, and students will find value in the journal's commitment to fostering knowledge exchange and encouraging innovation in healthcare, making it an essential resource for anyone invested in the medical sciences.

Medeniyet Medical Journal, published by GALENOS PUBL HOUSE, is a prominent open access journal based in Turkey, dedicated to advancing research and education in the field of medicine. Since its inception in 2001, this journal has provided a platform for sharing innovative research, case studies, and reviews across various aspects of general medicine, garnering a Q3 ranking in the 2023 category of Medicine (miscellaneous) with an impressive position in the Scopus ranks. With an essential focus on bridging theoretical and practical insights, Medeniyet Medical Journal aims to foster collaboration among researchers, healthcare professionals, and students globally. The journal's commitment to open access ensures that vital medical knowledge is readily available to all, enhancing global health literacy and enabling informed decision-making in clinical practices. Researchers and professionals are encouraged to contribute to this dynamic space and engage with a rapidly growing body of work that is critical to the advancement of healthcare.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

Acta Medica Portuguesa is a distinguished journal in the field of General Medicine, published by ORDEM MEDICOS. Since its inception, this open-access journal has been a vital platform for disseminating impactful research and reviews in various aspects of medicine, particularly from Portuguese and international perspectives. With an ISSN of 0870-399X and an E-ISSN of 1646-0758, it caters to a global audience and has been open-access since 2003, ensuring maximum reach and visibility of its contributions. Despite its recent Q4 ranking in the Medicine (miscellaneous) category for 2023, it holds a commendable rank of 248 out of 636 in Scopus, indicating a strong percentile standing of 61%. This journal not only chronicles pivotal findings and advances in the medical field but also fosters collaboration and dialogue among researchers, professionals, and students alike. Based in Portugal at AV ALMIRANTE GAGO COUTINHO, 151, LISBON 1749-084, PORTUGAL, Acta Medica Portuguesa continues to contribute significantly to the medical literature landscape, inviting submissions that offer novel insights and enhance medical knowledge.

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.